Rosmarinic Acid, a Bioactive Phenolic Compound, Inhibits Glutamate Release from Rat Cerebrocortical Synaptosomes through GABA_A Receptor Activation

• Main Authors: Che-Chuan Wang, Pei-Wen Hsieh, Jinn-Rung Kuo, Su-Jane Wang
• Format: Article
• Language: English
• Published: MDPI AG 2021-07-01
• Series: Biomolecules
• Subjects: rosmarinic acid; glutamate release; GABA_A receptor; voltage-gated Ca²⁺ channel; CaMKII; synapsin I
• Online Access: https://www.mdpi.com/2218-273X/11/7/1029

Rosmarinic acid, a major component of rosemary, is a polyphenolic compound with potential neuroprotective effects. Asreducing the synaptic release of glutamate is crucial to achieving neuroprotectant’s pharmacotherapeutic effects, the effect of rosmarinic acid on glutamate release was investigated in rat cerebrocortical nerve terminals (synaptosomes). Rosmarinic acid depressed the 4-aminopyridine (4-AP)-induced glutamate release in a concentration-dependent manner. The removal of extracellular calcium and the blockade of vesicular transporters prevented the inhibition of glutamate release by rosmarinic acid. Rosmarinic acid reduced 4-AP-induced intrasynaptosomal Ca²⁺ elevation. The inhibition of N-, P/Q-type Ca²⁺ channels and the calcium/calmodulin-dependent kinase II (CaMKII) prevented rosmarinic acid from having effects on glutamate release. Rosmarinic acid also reduced the 4-AP-induced activation of CaMKII and the subsequent phosphorylation of synapsin I, the main presynaptic target of CaMKII. In addition, immunocytochemistry confirmed the presence of GABA_A receptors. GABA_A receptor agonist and antagonist blocked the inhibitory effect of rosmarinic acid on 4-AP-evoked glutamate release. Docking data also revealed that rosmarinic acid formed a hydrogen bond with the amino acid residues of GABA_A receptor. These results suggested that rosmarinic acid activates GABA_A receptors in cerebrocortical synaptosomes to decrease Ca²⁺ influx and CaMKII/synapsin I pathway to inhibit the evoked glutamate release.